Literature DB >> 17264097

Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.

Yukio Maruyama1, Masaaki Nakayama, Kazunobu Yoshimura, Hirofumi Nakano, Hiroyasu Yamamoto, Keitaro Yokoyama, Bengt Lindholm.   

Abstract

BACKGROUND: Iron supplementation is a mainstay for management of renal anaemia in patients receiving haemodialysis (HD). Although it is well known that a single intravenous iron (IVIR) administration transiently enhances oxidative stress in HD patients, the consequence of repeated IVIR administration is still unknown. This study aims to clarify the time course of changes in serum 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of DNA oxidative injury, during a period of repeated IVIR administration in HD patients.
METHODS: Twenty-seven patients (62+/-14 years and 23 males) on long-term HD participated in this study. All patients had been on HD more than 6 months and none had received a blood transfusion or iron therapy in previous 6 months. The patients were divided into three groups according to the baseline haematocrit (Ht) and serum ferritin (FTN) levels as a marker of body iron stores: IVIR group (Ht<30% and FTN<100 ng/ml; n=7); High FTN group (Ht>or=30% and FTN>or=100 ng/ml; n=11); and low FTN group (Ht>or=30% and FTN<100 ng/ml; n=9). The IVIR group patients received 40 mg of ferric saccharate i.v. after each HD session until Ht increased by 5%. Serum 8-OHdG and other parameters were prospectively monitored for 10 weeks.
RESULTS: At baseline, the serum ferritin level was independently associated with 8-OHdG in a multiple regression model (total adjusted R2=0.47, P<0.01). All patients in the IVIR group achieved the target Ht level during the study. IVIR administration resulted in significant increases in 8-OHdG levels (0.22+/-0.07-0.50+/-0.16 ng/ml: baseline to 10 week) as compared with both the high FTN group (0.52+/-0.20-0.58+/-0.28 ng/ml) and the low FTN group (0.39+/-0.11-0.36+/-0.11 ng/ml) (ANOVA for repeated measures P<0.01). Additionally, serum 8-OHdG and serum ferritin changed in the same manner.
CONCLUSIONS: Repeated IVIR administration for HD patients was associated with signs of increased oxidative DNA injury, as reflected by increased serum levels of 8-OHdG. As these changes were accompanied by increased serum ferritin levels, excess body iron stores might play an important role in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264097     DOI: 10.1093/ndt/gfl789

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

2.  Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.

Authors:  Vaijinath S Kamanna; Shobha H Ganji; Stanislav Shelkovnikov; Keith Norris; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2011-12-29       Impact factor: 3.754

Review 3.  The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina; Doron Schwartz
Journal:  Clin Exp Nephrol       Date:  2008-08-01       Impact factor: 2.801

4.  Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Yau-Huei Wei; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

Review 5.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

6.  Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy.

Authors:  A Jairam; R Das; P K Aggarwal; H S Kohli; K L Gupta; V Sakhuja; V Jha
Journal:  Indian J Nephrol       Date:  2010-07

7.  Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry.

Authors:  Takayuki Hamano; Naohiko Fujii; Terumasa Hayashi; Hiroyasu Yamamoto; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

8.  Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.

Authors:  Chie Ogawa; Ken Tsuchiya; Naohisa Tomosugi; Fumiyoshi Kanda; Kunimi Maeda; Teiryo Maeda
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

9.  Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.

Authors:  Paul S Stadem; Megan V Hilgers; Derrick Bengo; Sarah E Cusick; Susan Ndidde; Tina M Slusher; Troy C Lund
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

Review 10.  Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Norishi Ueda; Kazuya Takasawa
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.